Dyne Therapeutics reported cash from operations of -$130.29M and free cash flow of -$125.69M for the quarter ended Jun 2026, down 37.6% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -42.58M | -51.78M | -36.44M | -52.98M | -41.38M | -38.80M | -45.10M | -66.59M | -60.08M | -65.94M | -69.29M | -72.07M | -96.29M | -89.52M | -122.14M | -109.26M | -108.32M | -108.47M | -125.89M | -173.87M | ||||||||
| Share-based Compensation | 7.33M | 6.01M | 7.95M | 8.09M | 8.35M | 3.83M | 9.28M | 9.16M | 9.09M | 5.73M | 19.91M | 8.36M | 8.74M | 10.48M | 13.02M | 10.52M | 11.08M | 11.23M | 13.08M | 14.98M | ||||||||
| Cash from Operations | -26.95M | -28.07M | -50.74M | -30.91M | -42.80M | -29.19M | -46.91M | -55.64M | -50.60M | -35.01M | -78.54M | -54.87M | -74.63M | -84.33M | -105.89M | -94.70M | -90.78M | -111.83M | -144.92M | -130.29M | ||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||
| Amortizatization of Intangibles | ||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.30M | 0.35M | 0.42M | 0.50M | 0.40M | 0.38M | 0.41M | 0.40M | 0.40M | 0.40M | 0.40M | 0.40M | 0.40M | 0.48M | 0.50M | 0.50M | 0.50M | 0.52M | 0.60M | 0.60M | ||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||
| Change in Accured Expenses | 4.83M | 6.03M | -6.27M | 1.54M | -1.16M | 4.65M | -6.53M | -1.37M | 9.46M | 21.41M | -28.76M | 7.38M | 13.41M | -0.99M | -8.60M | 7.84M | 18.47M | -9.46M | -4.80M | 18.96M | ||||||||
| Other Working Capital Changes | -8.58M | -11.31M | 15.48M | -14.82M | 4.00M | -0.51M | 1.39M | -5.57M | 4.96M | -4.12M | 4.07M | 3.14M | -0.77M | 4.09M | -5.00M | 2.20M | -0.39M | 2.20M | 32.85M | -9.48M | ||||||||
| Investing Activities | ||||||||||||||||||||||||||||
| Capital Expenditures | 0.88M | 1.99M | 1.40M | 0.26M | 0.89M | 0.52M | 0.23M | 0.25M | 0.17M | 0.08M | 0.19M | 0.86M | 0.25M | 1.07M | 0.98M | 0.06M | 17.75M | 0.22M | -4.60M | |||||||||
| Change in Acquisitions & Divestments | 4.44M | 2.52M | 0.24M | 0.40M | 1.83M | 1.75M | 8.81M | 2.97M | 5.50M | 0.00M | 9.38M | 28.65M | 14.77M | |||||||||||||||
| Cash from Investing Activities | -2.85M | -0.23M | -2.14M | 18.44M | 51.66M | 19.24M | 27.06M | 17.23M | 12.82M | 26.20M | -179.84M | 11.17M | -19.40M | -16.01M | 1.46M | 6.77M | -37.97M | 0.98M | -2.39M | -4.79M | ||||||||
| Financing Activities | ||||||||||||||||||||||||||||
| Other financing activities | 0.46M | 0.09M | 0.02M | 0.10M | 0.07M | 0.34M | 0.59M | 0.76M | 0.45M | 0.15M | 10.92M | 4.28M | 18.01M | 3.64M | 0.59M | 1.97M | 2.07M | 3.37M | 1.31M | 0.74M | ||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||||
| Long-Term Debt Issuances | 49.45M | |||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 2.24M | 0.18M | 2.27M | 0.21M | 1.69M | 0.85M | 3.60M | 0.48M | 3.78M | 2.85M | ||||||||||||||||||
| Net Equity Issued and Repurchased | 28.23M | 24.14M | -0.00M | 73.62M | 24.25M | 140.65M | 377.70M | |||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||
| Cash from Financing Activities | 0.46M | 0.09M | 0.02M | 0.10M | 0.07M | 37.20M | 28.82M | 24.91M | 0.45M | 0.15M | 408.39M | 379.86M | 18.01M | 3.64M | 141.24M | 100.77M | 217.33M | 430.96M | 7.06M | 58.11M | ||||||||
| Change in Cash | -29.34M | -28.21M | -52.86M | -12.37M | 8.92M | 27.25M | 8.97M | -13.50M | -37.33M | -8.66M | 150.01M | 336.17M | -76.02M | -96.71M | 36.81M | 12.85M | 88.58M | 320.12M | -140.25M | -76.97M | ||||||||
| Free Cash Flow | -27.83M | -30.06M | -52.14M | -31.17M | -43.69M | -29.71M | -47.14M | -55.89M | -50.77M | -35.09M | -78.73M | -55.73M | -74.88M | -85.41M | -106.87M | -94.76M | -108.53M | -111.83M | -145.14M | -125.69M | ||||||||
| Net Cash Flow | -29.34M | -28.21M | -52.86M | -12.37M | 8.92M | 27.25M | 8.97M | -13.50M | -37.33M | -8.66M | 150.01M | 336.17M | -76.02M | -96.71M | 36.81M | 12.85M | 88.58M | 320.12M | -140.25M | -76.97M |